AEMD
AETHLON MEDICAL INC (AEMD
NASDAQ · Healthcare · Medical - Devices · US
$5.16
+0.19%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- +46.5%
- EBIT
- +16.8%
- EPS
- +82.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- +73.4%
Three-year CAGR
- Revenue
- —
- EBITDA
- +47.7%
- EBIT
- +21.9%
- Net income
- +46.6%
- EPS
- +87.6%
- Free cash flow
- +8.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026